Physician profile
Joe M Llenos
NPI 1003073560
$304.84
in general payments reported to CMS, 2019-2025
10 companies · $95.12 in 2025
The $95.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.78 · 2020: $14.90 · 2021: $37.45 · 2022: $18.77 · 2023: $35.65 · 2024: $78.17 · 2025: $95.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $52.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $52.60 | 2023-2024 | Puraply |
| Abbvie INC. | $51.22 | 2022-2025 | |
| Abbott Laboratories | $47.22 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $23.41 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Smith+Nephew, INC. | $21.22 | 2024 | Grafix Pl |
| Mimedx Group, INC. | $20.43 | 2024 | |
| Dexcom, INC. | $15.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2020 | |
| Organon LLC | $5.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Llenos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.